We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+2.4%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$537B
AUM Growth
-$38.8B
Cap. Flow
-$65.7B
Cap. Flow %
-12.23%
Top 10 Hldgs %
26.27%
Holding
13,638
New
1,591
Increased
4,593
Reduced
5,607
Closed
1,726

Sector Composition

Rank Sector Weight
1 Technology 2.38%
2 Consumer Discretionary 1.03%
3 Financials 0.75%
4 Healthcare 0.67%
5 Communication Services 0.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CINT icon
12076
PUT
CI&T Inc
CINT
$452M
-12,700
Closed -$52.5K
CIO
12077
PUT
DELISTED
City Office REIT
CIO
-16,500
Closed -$86K
DCX
12078
Digital Currency X Technology Inc
DCX
$343M
0
-$6.59K
CLB icon
12079
PUT
Core Laboratories
CLB
$552M
-10,200
Closed -$174K
CLBK icon
12080
Columbia Financial
CLBK
$1.21B
-10,463
Closed -$180K
CLBT icon
12081
CALL
Cellebrite
CLBT
$2.84B
-56,500
Closed -$626K
CLLS
12082
Cellectis
CLLS
$344M
-27,655
Closed -$72.5K
CLOU icon
12083
CALL
Global X Cloud Computing ETF
CLOU
$366M
-39,400
Closed -$857K
CLPR
12084
CALL
Clipper Realty
CLPR
$56.1M
-19,900
Closed -$96.1K
CLPR
12085
Clipper Realty
CLPR
$56.1M
-17,982
Closed -$86.9K
CLPR
12086
PUT
Clipper Realty
CLPR
$56.1M
-37,000
Closed -$179K
CLRB icon
12087
CALL
Cellectar Biosciences
CLRB
$23.8M
-353
Closed -$42.2K
CLSD
12088
CALL
DELISTED
Clearside Biomedical
CLSD
-947
Closed -$21.7K
CLVT icon
12089
CALL
Clarivate
CLVT
$1.36B
-28,200
Closed -$210K
CM icon
12090
Canadian Imperial Bank of Commerce
CM
$107B
-4,701
Closed -$228K
CMBM
12091
CALL
DELISTED
Cambium Networks
CMBM
-39,600
Closed -$171K
CMMB
12092
Chemomab Therapeutics
CMMB
$16.9M
-2,869
Closed -$8.94K
CMND icon
12093
Clearmind Medicine
CMND
$2.48M
-60
Closed -$27.3K
CMP icon
12094
CALL
Compass Minerals
CMP
$1.02B
-73,400
Closed -$1.16M
CMPOW
12095
DELISTED
CompoSecure Inc Warrant
CMPOW
-10,705
Closed -$7.49K
CMTG icon
12096
CALL
Claros Mortgage Trust
CMTG
$244M
-53,200
Closed -$519K
CMTG icon
12097
Claros Mortgage Trust
CMTG
$244M
-12,937
Closed -$110K
CNM icon
12098
Core & Main
CNM
$8.27B
-18,304
Closed -$1.02M
CNMD icon
12099
CALL
CONMED
CNMD
$1.52B
-21,600
Closed -$1.73M
CNO icon
12100
CNO Financial Group
CNO
$4.99B
-33,857
Closed -$930K

Similar funds

Jeff Yass's Q2 2024 Portfolio in Review

As of Q2 2024, Jeff Yass held 13,638 positions worth $537B, down 6.7% from $576B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Jeff Yass withdrew a net $65.7B in Q2 2024, closing 1,726 positions and reducing 5,607 holdings. Its most notable exit was iShares MSCI USA Quality Factor ETF, an estimated $26.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Jeff Yass opened a new position in NextEra Energy 7.299% Corporate Units worth $127M.

  • Jeff Yass's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M.
  • Jeff Yass added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $521M increase.
  • Jeff Yass's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $5.31B.
  • Jeff Yass fully exited iShares MSCI USA Quality Factor ETF in Q2 2024, selling an estimated $26.2M.
  • Jeff Yass's ten largest holdings make up 26% of its $537B portfolio in Q2 2024.
  • Jeff Yass opened 1,591 new positions and closed 1,726 in Q2 2024.
  • Jeff Yass's portfolio value fell 6.7% quarter-over-quarter to $537B.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.